The government is in advanced talks with US pharmaceutical giant Johnson & Johnson (J&J) to secure an additional 20-million doses of its Covid-19 vaccine, after plans to start inoculating health-care workers with AstraZeneca’s shot hit a major stumbling block at the weekend.

The Anglo-Swedish company’s offering was intended to be the cornerstone of the first phase of SA’s coronavirus vaccination drive, as it is relatively cheap and easy to store...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now